Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. Show More...
-
Website https://www.dyadic.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.04 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2004-12 2005-12 2006-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -0.37 -0.48 -0.45 -0.010 -0.18 1.91 -0.1 -0.07 -0.21 -0.31 -0.31 Dividends USD Payout Ratio % * Shares Mil 16.0 22.0 24.0 33.0 34.0 34.0 37.0 29.0 28.0 27.0 27.0 Book Value Per Share * USD 0.78 0.66 0.03 -0.02 1.95 1.83 1.61 1.36 1.25 Free Cash Flow Per Share * USD -0.45 -0.38 0.08 0.02 -0.2 -0.09 -0.19 -0.21 Return on Assets % 26.87 -37.24 -31.59 -2.87 -50.95 154.43 -5.33 -3.9 -12.1 -20.58 -21.61 Financial Leverage (Average) 1.34 1.56 1.6 5.82 1.04 1.02 1.02 1.02 1.04 1.03 Return on Equity % 36.05 -52.92 -50.08 -16.67 183.94 -5.49 -3.97 -12.32 -21.22 -22.31 Return on Invested Capital % 28.14 -52.34 -44.71 2.25 -63.84 183.91 -5.93 -3.97 -12.32 -23.05 -24.04 Interest Coverage 0.38 -7.75 Current Ratio 6.39 4.59 9.31 3.35 2.83 24.08 57.04 64.53 50.31 22.44 28.89 Quick Ratio 4.86 3.24 7.68 2.59 1.33 23.9 49.51 63.01 49.81 22.27 28.64 Debt/Equity 0.13 0.08 3.21